Objective. To examine the performance of ultrasound (US) for the diagnosis of gout using the presence of monosodium urate monohydrate (MSU) crystals as the gold standard.
used to examine factors associated with positive US results among subjects with gout.
Results. US was performed in 824 subjects (416 cases and 408 controls). The sensitivity, specificity, PPV, and NPV for the presence of any 1 of the features were 76.9%, 84.3%, 83.3%, and 78.2%, respectively. Sensitivity was higher among subjects with a disease duration of ‡2 years and among subjects with subcutaneous nodules on examination (suspected tophus). Associations with a positive US finding included suspected clinical tophus (odds ratio Conclusion. US features of MSU crystal deposition had high specificity and high PPV but more limited sensitivity for early gout. The specificity remained high in subjects with early disease and without clinical signs of tophi.
While the presence of monosodium urate monohydrate (MSU) crystals in the synovial fluid is the gold standard for the diagnosis of gout, musculoskeletal ultrasound (MSUS) is increasingly used in studies of gout and for establishing a diagnosis of gout in clinical practice (1) . MSU crystal deposition can be identified on US by hyperechoic irregular enhancement of the articular surface of the hyaline cartilage (double contour sign), hyperechoic aggregates suggestive of tophi within the joint or along tendons, and floating hyperechoic foci within the joint space which have the appearance of a snowstorm (1) . Previous studies have suggested reasonable test characteristics of these features, double contour sign and tophi in particular (2) (3) (4) (5) (6) (7) (8) . However, most studies examining the diagnostic properties of US in gout have been single-center studies of relatively small size, with a few exceptions, and most of the subjects enrolled in these studies have had longstanding disease. Additionally, most previous studies have involved centers with MSUS world experts, which may not reflect the accuracy of US in real-life clinical practice. Finally, many existing studies are limited by suboptimal characterization of the control groups (i.e., arthrocentesis was not performed in subjects in the comparator groups) (4) .
In the Study for Updated Gout Classification Criteria (SUGAR), a large, international, multicenter crosssectional study, multivariate logistic regression analysis showed that US findings contributed independently to identification of gout with an odds ratio of 7.2. These results suggested that US provides a useful contribution to discrimination between gout and non-gout and that the effectiveness of the presence of a US feature for discriminating gout is similar to that of clinical identification of tophi (9) .
The objectives of the present study were to determine the sensitivity and specificity of US features for the diagnosis of gout in this international cohort and better understand the test characteristics in early versus late disease and among those with versus those without clinically suspected tophus on examination. The primary goal was to determine how US performs in the clinical practice setting. Thus, a scanning protocol and study-specific training were not provided. Additionally, we sought to determine subject and disease characteristics associated with positive US findings.
PATIENTS AND METHODS
Study design and setting. We analyzed data from SUGAR, a large, multicenter, observational cross-sectional study designed to inform new gout classification criteria (9) . Standardized US analysis was included in the data collection, but it was not mandatory.
Study population and gold standard. Consecutive subjects from rheumatology clinics who had $1 swollen joint or a subcutaneous nodule and conceivably may have had gout (i.e., gout was on the differential diagnosis for the patient's joint swelling) were enrolled (9) . All subjects underwent arthrocentesis or soft tissue nodule aspiration to establish a crystal-based diagnosis. Twenty-five centers from around the world participated. Subjects in the SUGAR cohort who underwent a US examination were included in the present analysis. The gold standard test was the presence of MSU crystals in the joint fluid. Crystal identification was performed by trained observers who were required to pass a certification procedure, which included a web-based crystal recognition test and the examination of 5 vials of synovial fluid. This has been described in more detail in the study by Taylor et al (9) . Only sites with participants who completed this certification were able to participate in the study. Cases were subjects with confirmed MSU crystals, and controls were subjects with a joint fluid or soft tissue nodule aspirate that was negative for MSU crystals. In a sensitivity analysis, those with clinically suspected gout who did not have MSU crystals were also included as cases to better understand the impact of restricting the cases to those with confirmed MSU crystals.
Ultrasound. US was performed on 1 or more clinically affected joints by either rheumatologists or radiologists who were blinded with regard to the aspiration results. All ultrasonographers had prior US training. US double contour sign was defined as a hyperechoic band on the surface of the articular cartilage (10) . US tophus was defined as the presence of a hyperechoic, heterogeneous lesion surrounded by an anechoic rim (10, 11) . US snowstorm was defined as a "snowstorm type joint effusion" (12) . These definitions were provided in the clinical research form. Ultrasonographer training and type of equipment used are listed in Supplementary Clinical data and covariates of interest. Data collected at the time of enrollment are reported in detail in the SUGAR study (9) . Covariates included age, sex, ethnicity, number of episodes of joint swelling, use of urate-lowering therapy, weeks since first episode, disease duration, and history of podagra (first metatarsophalangeal [MTP] joint involvement). A physical examination was performed, and the location of tender and swollen joints, a count of involved joints, and presence of suspected tophus on examination were recorded. Current and highest ever (from any available records) serum urate levels and presence of radiographic abnormalities were also recorded.
Test characteristics for gout compared with calcium pyrophosphate deposition disease (CPDD). Because a recent study suggested difficulty differentiating gout from CPDD on US (13), we additionally examined specificity when US features were compared between subjects with MSU-positive gout and those with CPDD (sensitivity would be the same as in the previous analyses). CPDD was defined by the presence of calcium pyrophosphate crystals in the synovial fluid. Subjects with clinically suspected gout, but who were MSU negative, were not included in this analysis.
Statistical analysis. Demographic data were descriptively reported. Differences between those with and those without a US examination in the SUGAR cohort were examined using the chi-square test or Wilcoxon's rank sum test as appropriate. Among subjects with US, we examined sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the 3 features individually (double contour sign, tophus, and snowstorm appearance) or the presence versus the absence of any 1 of the features in all subjects with gout versus controls and then separately within subgroups defined by 2 factors: early disease (defined as ,2 years since first symptom onset/gout attack) versus late disease, and subjects with versus those without clinically suspected tophus on examination (14) . We additionally examined the test characteristics of having 1, 2, or all 3 of these features present. Sensitivity was calculated as true positives/(true positives 1 false negatives). Specificity was calculated as true negatives/(false positives 1 true negatives). PPV was calculated as true positives/(true positives 1 false positives), and NPV was calculated as true negatives/(true negatives 1 false negatives).
Finally, we examined factors associated with having a positive US finding among cases. The goal of this analysis was to gain insight into what factors may influence the test results. We first performed univariable logistic regression to examine the association between single factors and the presence of a positive test (among cases with gout only). Age, sex, and all variables that were significant at the univariable level (P , 0.1) were placed into a multivariable model. Covariates with the highest P value were then removed one by one until only significant covariates (P , 0.05) remained in the model. Age and sex were retained in all models given their biologic significance.
Sensitivity analysis. We examined the impact of changing the definition of gout to a physicians' diagnosis of gout rather than MSU-positive gout. Next, we stratified the analysis by ultrasonographer's years of experience using MSUS (dichotomized as ,10 years or $10 years). In addition, we examined the test characteristics among patients with and those without a tender or swollen first MTP joint, since the presence of MTP joint symptoms may have influenced the ultrasonographer. Finally, we examined subgroups of men with hyperuricemia to determine whether subclinical hyperuricemia may have led to more false positives in patients without clinical gout.
RESULTS
Baseline characteristics. Among the 982 subjects enrolled in SUGAR, US was performed in 824 (416 cases and 408 controls). The baseline characteristics of the US group (Table 1) were reflective of the larger SUGAR population with a few exceptions. Subject characteristics among those with and those without a US examination are shown in Supplementary Table 2, available on the Arthritis & Rheumatology web site at http://onlinelibrary. wiley.com/doi/10.1002/art.39959/abstract. Relatively fewer subjects of white and African-American or African ethnicity had a US performed (whereas the majority of Hispanics, South Asians, and East Asians had a US performed). The mean serum urate level was slightly lower in the US group (0.41 mmole/liter versus 0.45 mmole/liter; P 5 0.001), and patients who underwent US had a higher prevalence of tender joints proximal to the ankle (72% versus 63%; P 5 0.02) and swollen joints proximal to the ankle (73% versus 63%; P 5 0.01).
Among subjects included in the US analysis, the mean 6 SD age was 60.2 6 14.6 years for cases and 59.5 6 16.0 years for controls, respectively, and 87% and 54% were male, respectively (Table 1) . Twenty-six percent of MSU-positive gout subjects had a disease duration of ,2 years, whereas 48% of controls had a disease duration of ,2 years. The majority of subjects had more than 5 episodes of joint flares (69% and 49% of cases and controls, respectively). The control subjects were diagnosed as having CPDD (n 5 98), clinically suspected gout (n 5 41), osteoarthritis (n 5 63), rheumatoid arthritis (n 5 59), spondyloarthritides (n 5 60), undifferentiated inflammatory arthritis (n 5 47), septic arthritis (n 5 7), systemic lupus erythematosus (n 5 5), and other (n 5 28). US was performed for a single joint in most patients; however, it was performed for more than 1 joint in 16% of the patients. The most commonly examined joints were the knees, MTP joints, and ankles (Supplementary  Table 3 , and NPV was 65.6% (95% CI 59.6-67.4). The sensitivity for snowstorm appearance was 30.3% (95% CI 25.9-35.0), specificity was 90.9% (95% CI 87.7-93.5), PPV was 77.2% (95% CI 69.9-83.4), and NPV was 56.3% (95% CI 52.4-60.1). When the presence of any 1 of the 3 features was considered a positive finding, the sensitivity was 76.9% (95% CI 72.6-80.9), specificity was 84.3% (95% CI 80.4-87.7), PPV was 83.3% (95% CI 79.2-86.9), and NPV was 78.2% (95% CI 74.0-82.0).
We additionally examined the test characteristics of the US features among the subsets of subjects with early disease (defined as 2 years or fewer of symptom duration; 109 cases and 195 controls) versus late disease (304 cases and 209 controls), and of subjects in whom there were no suspected tophi (or subcutaneous nodules) present on examination (265 cases and 389 controls) versus those with suspected tophi on examination (150 cases and 19 controls). Overall, sensitivity and specificity were not substantially different in the subgroups except among patients with a suspected tophus on examination. Sensitivity and PPV were higher, and specificity and NPV were lower, among subjects with suspected tophi (Table 2 ). In a sensitivity analysis, we included subjects in the "gout" group who were clinically diagnosed as having gout but had an aspirate that was negative for MSU crystals (n 5 41); this did not substantially change the results, except among patients with a clinically suspected tophus on examination; for these subjects, the specificity improved for all 3 features and the composite outcome (Supplementary Table 4 , available on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.39959/abstract). We additionally examined the test characteristics of having 1, 2, or 3 features of gout on US (Table 3 and Figure 1 ). Sensitivity and NPV decreased as the number of features of gout increased, and specificity for gout increased as the number of features increased. The PPV remained relatively high.
In sensitivity analyses, we examined whether patient or sonographer characteristics affected the test characteristics for double contour sign, tophus, snowstorm appearance, or having any positive feature (Supplementary Overall, specificity was relatively unchanged. Sensitivity of double contour sign and tophus on US increased with increasing duration of disease. Performance of US features among subjects with gout and CPDD. We examined the specificity of the same US features for gout in subjects with calcium pyrophosphate-positive aspirates. (Sensitivity is the same since this is calculated from the cases.) When compared to subjects with CPDD, US features still had a relatively high specificity (81-95%) and PPV (93-97%) for gout (Table  4) . Of note, subjects with CPDD were more likely to have ,2 years of symptoms (52.8% of those with CPDD versus 26.4% of those with gout; P , 0.001).
Associations with positive US findings among cases. Finally, we sought to determine which patients with gout were most likely to have positive US findings. Associations with positive US findings among cases are shown in Figure 1 . Percentage of patients with 1 or more ultrasound (US) features of gout. The majority of patients with monosodium urate monohydrate (MSU)-positive gout (77%) had at least 1 positive US feature of gout, whereas the majority of controls without calcium pyrophosphate deposition disease (CPDD) or a clinical diagnosis of gout (92%) had negative US findings. Table 5 . After adding age and sex, the subject characteristics most strongly associated with a double contour sign were the highest serum urate level ever, joint tenderness proximal to the ankle, and any radiographic feature of gout (erosion, asymmetric swelling, or cyst). Suspected tophus on examination, current serum urate level, and asymmetric swelling on plain radiography were significantly associated with identification of tophus on US. Suspected tophus on examination and cysts on plain radiography were positively associated with snowstorm appearance on US, whereas the number of episodes was negatively associated with snowstorm appearance. Finally, suspected tophus on examination, current serum urate level, and having any radiographic abnormality were strongly associated with having any US feature of gout.
DISCUSSION
We found high specificity (.90% for individual features) and PPV for US of clinically symptomatic joints when using MSU positivity as the gold standard. However, sensitivity was better for those with longstanding disease ($2 years of symptoms or tophi) than those with early disease or without suspected tophi on examination. Thus, the absence of 1 of these features does not rule out the disease. Additionally, the US features of double contour sign and tophi had high specificity for gout even when compared with patients with CPDD, suggesting that these features still allow for differentiation between gout and CPDD. A positive US finding indicative of gout among subjects with MSU-positive gout was associated with suspected tophi on examination, higher serum urate level, and abnormal * Except where indicated otherwise, values are the number (%) of subjects. Five subjects who had both calcium pyrophosphate deposition disease (CPDD) and monosodium urate monohydrate (MSU) crystals were classified as having gout rather than CPDD. 95% CI 5 95% confidence interval; PPV 5 positive predictive value; NPV 5 negative predictive value. radiographic findings. Thus, positive US findings may be associated with a higher urate burden in general. Overall, these results suggest that, while US performs best in patients who would likely be more easily diagnosed without imaging (e.g., patients with tophi), US is still useful in patients without obvious gout on examination (e.g., without tophi, without MTP joint tenderness or swelling) and specificity remains high (;90%) in these subgroups. In a previous meta-analysis, we summarized 9 studies and 2 meeting abstracts examining the sensitivity and specificity of US for the diagnosis of gout compared with MSU crystals as the gold standard (4). In the metaanalysis, the US features of double contour sign and tophi had a pooled sensitivity of 83% and 65%, respectively, and a pooled specificity of 76% and 80%, respectively (there were insufficient data on snowstorm appearance to generate pooled sensitivity and specificity). Compared with the pooled test characteristics in the meta-analysis, sensitivity was lower and specificity was higher in the present study. This may be related to differences in the subject characteristics in our study compared to previous studies. Sensitivity and specificity, while test characteristics, are tied to the population studied and the reference standard used. The present study included more subjects with early disease relative to previous studies. Additionally, our study enrolled subjects who had a clinical presentation that could be consistent with gout. Arguably, this is the population in which US is most useful as a diagnostic test. Many of the studies included in this meta-analysis used comparator groups that were less likely to have a diagnosis of gout and may have been less likely to have active joint disease. A recent single-center examination of the test characteristics of US in a similar population to those enrolled in our study reported sensitivity of 74% and specificity of 82% for any US feature (15) . This was similar to our findings for any US feature (sensitivity 77% and specificity 84%).
Because sensitivity and specificity are tied to the populations studied, one of the strengths of our study was the ability to look at these test characteristics among subgroups. We found a higher sensitivity for those with a disease duration of .2 years but similar specificity among these groups. US had a higher sensitivity among subjects with suspected tophus on examination compared to those without, but much lower specificity. There were a relatively larger number of "positive" US findings among subjects with suspected tophus on examination but aspirations negative for MSU crystals (8 of 19 subjects), and specificity is calculated as the number of true negatives divided by the number of subjects without gout. These subjects may in fact have had gout but the "active" joint was related to a different diagnosis or the MSU crystals were missed by the certified assessors. As noted in the SUGAR study, suspected tophus on examination may be a stronger predictor of existing gout than US features (9) . Furthermore, when we reclassified patients according to clinician diagnosis, the specificity increased substantially in the subgroup of patients with suspected tophus on examination.
In addition to the subgroups described above, we also compared the test characteristics of US in patients with MSU-positive gout with the subgroup of controls with CPDD. CPDD is associated with similar US findings (12, 13, (16) (17) (18) (19) . In our study, the specificity of US for gout remained .80%. We found relatively few subjects with CPDD and US changes attributed to urate deposition. A recent meta-analysis by Gamon et al (17) found that sensitivity and specificity of US in CPDD varies by the joint or tendon analyzed. It may be that joints specific for gout (in general lower extremities) have lower sensitivity for CPDD. Alternatively, it may be that the subjects with CPDD in this study may have had fewer positive test results related to shorter disease duration.
Our study is a unique contribution to the literature in that it is an examination of a real-life, multicenter experience of US in the assessment of gout features. Additionally, this study examined the performance characteristics of double contour sign, tophus, and snowstorm appearance. Most previous studies have mainly focused on double contour sign and tophus with very few examining test characteristics of snowstorm appearance. Finally, we used MSU crystal analysis as the gold standard when calculating sensitivity and specificity, which included confirming the absence of MSU crystals in controls, and we required all investigators to be certified in MSU crystal identification. The use of a rigorous gold standard is of critical importance when determining the sensitivity and specificity of a diagnostic test.
Limitations of this study include possible selection bias, variation in ultrasonographer training and US machine use, and possible test interpretation bias. US was not performed in all subjects in the SUGAR study due to the availability of US and trained ultrasonographers at the enrolling sites. However, there were few differences in the subjects who did undergo US versus those who did not. This suggests that there was not a significant selection bias with regard to which subjects underwent US.
A variety of machines were used and many different ultrasonographers performed the US. Ultrasonographers were mainly rheumatologists who used US in clinical practice, although they were not necessarily certified, or radiologists. Although definitions of US features were provided to all ultrasonographers, a standardized scanning protocol was not required. Interrater reliability was not assessed; this has been reported previously (6, 20, 21) and was not the primary goal of the study. There was some variability in the 436 OGDIE ET AL false-positive and false-negative rates at the individual sites (data not shown). We did not have the ability to centrally re-read US images. However, this reflects "real-world" use of US in clinical practice, increasing the external validity of the results. Understanding US performance in the "real world" was the primary objective of this study (acknowledging that this is still under "study" conditions). Next, only clinically affected joints were scanned. Inclusion of additional asymptomatic joints may have increased the sensitivity. However, our primary goal was to assess the ability of US to assist in diagnosing gout in the symptomatic joint. Test interpretation bias is possible, although it should not have a significant influence given that US was performed by investigators who were blinded with regard to synovial fluid analysis. Importantly, ultrasonographers may not have been blinded with regard to all clinical features; for example, it is possible that the presence of visible tophi or other clinically apparent characteristics influenced the interpretation of the US results. However, this also reflects real-life clinical practice, in which US is used in addition to available clinical data. Finally, it is important to recognize that these data are relevant for patients with symptomatic joint swelling. These results cannot be applied to diagnosis of gout in patients with asymptomatic hyperuricemia.
In conclusion, MSUS had high specificity for the diagnosis of gout among subjects with at least 1 swollen joint and a clinical presentation that could be consistent with gout, but sensitivity was modest. The specificity remained high for patients with early disease and without clinical signs of tophi, the population in which US may be the most useful in establishing a diagnosis of gout.
